News in the Life Sciences Industry

ABBOTT PARK, Ill., March 14, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it received approval from the U.S. Food and Drug Administration (FDA) for a new, expanded indication to its leading MitraClip((TM) )device used to repair a leaky mitral valve without open-heart surgery. Supported... Read more ››

ANYANG, South Korea and COLOGNE, Germany, March 12, 2019 /PRNewswire/ -- Vieworks, a global leader in x-ray imaging solution, presents the Dental Lineups at the International Dental Show (IDS) 2019 (hall 2.1 C-080) from 12 to 16 March 2019. IDS, the world's biggest trade fair for dentistry and... Read more ››

BRUSSELS, March 11, 2019 /PRNewswire/ -- UCB, a global biopharmaceutical company, announced detailed findings from the investigational study C-AXSPAND, the Phase 3, multi-center, double-blind, placebo-controlled study conducted over 52 weeks, demonstrating positive results for CIMZIA® (certolizumab... Read more ››

OSAKA, Japan, March 8, 2019 /PRNewswire/ -- Santen Pharmaceutical Co., Ltd. (hereinafter "Santen") announced on March 8 that as part of its initiatives to increase public awareness of glaucoma, it will sponsor activities to be conducted worldwide during World Glaucoma Week (hereinafter "WGW")... Read more ››

DÜSSELDORF, Germany and SKOPJE, Macedonia, March 7, 2019 /PRNewswire/ -- Gerresheimer AG is to build a new plant in Skopje, Republic of North Macedonia. "As part of our growth strategy, we require additional manufacturing capacity and are expanding our European production network. We will... Read more ››

CORK, Ireland, March 7, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson confirmed that the novel, investigational, long-acting two-drug injectable regimen of rilpivirine and cabotegravir met its primary endpoints in two major Phase 3 studies - the Antiretroviral... Read more ››

BASEL, Switzerland, March 5, 2019 /PRNewswire/ -- Mundipharma EDO GmbH, part of the Mundipharma global network of independent associated companies, today announced that the first patient has been enrolled in the expansion stage of a Phase I/II clinical trial of tinostamustine in patients with... Read more ››

BURGWEDEL, Germany, March 5, 2019 /PRNewswire/ -- MYR Pharma announced today that the British Medicines and Healthcare products Regulatory Agency (MHRA) has issued the Promising Innovative Medicine (PIM) designation for MYR's lead compound Bulevirtide (Myrcludex). The designation is granted in... Read more ››

- PepsiCo's Former Vice Chairman and Chief Scientific Officer, Former President of Global R&D, Takeda Pharmaceuticals, to Lead Longevity Biotech -

- Patent covers paired Cas9 nickase technology to advance gene therapy and research, reduce off-target effects

VIENNA, March 4, 2019 /PRNewswire/ -- Esaote announces the launch of the MyLab™X8 - the high-performance and versatile ultrasound platform to support hospitals and clinics facing today's challenges - at the European Congress of Radiology, ECR 2019 at booth number X5/510.